H.P. Acthar® Gel ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
14Chronic inflammatory demyelinating polyneuropathy1

14. Chronic inflammatory demyelinating polyneuropathy


Clinical trials : 167 Drugs : 158 - (DrugBank : 38) / Drug target genes : 13 - Drug target pathways : 23
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02574962
(ClinicalTrials.gov)
August 201530/8/2015Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating NeuropathyPilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating NeuropathyChronic Inflammatory Demyelinating PolyneuropathyDrug: H.P. Acthar® GelMamatha Pasnoor, MDMallinckrodtWithdrawn18 YearsN/ABoth0Phase 2United States